Neuron7 is an enterprise AI company that builds 'service resolution intelligence' for complex post-sale support. Founded in 2020 by Niken Patel, the company operates across the U.S. and India (with significant engineering in Bengaluru) and focuses on a specific, high-value problem: helping service organizations resolve complicated technical issues quickly and consistently. Its customers are typically in demanding sectors such as medical devices, industrial manufacturing, and high-tech equipment, where accurate diagnosis and fast resolution directly affect uptime, safety, and cost.
The platform ingests an organization's service data, knowledge bases, manuals, and the tacit expertise of senior technicians, then uses AI to recommend the most likely root causes and resolution paths for incoming issues. By guiding agents and field-service teams to proven answers, Neuron7 aims to reduce mean time to resolution, cut unnecessary part replacements and truck rolls, and capture expert knowledge before it walks out the door. It positions itself as augmenting human experts rather than replacing them, surfacing the right next step in the flow of work.
Neuron7 has raised more than $63 million in total. After a $10 million Series A led by Battery Ventures and Nexus Venture Partners, it closed a $44 million Series B in October 2024 led by Smith Point Capital, the firm associated with a former Salesforce co-CEO, with existing investors Nexus and Battery participating. The capital is being used to scale operations, including expanding its Bengaluru hub as a global center for AI engineering.
Neuron7's differentiation is its depth in complex service domains and its focus on measurable resolution outcomes rather than generic chatbots. Risks include long enterprise sales cycles and the challenge of integrating into varied service workflows and legacy systems.
For enterprises with complex products and high-stakes service operations, Neuron7 offers specialized AI to improve resolution quality and speed.